ARCHIVES

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

This article is from The Cancer Letter archive.

Vol. 40 No. 12 | March 21, 2014

Download PDF Visit The Full Archive

Related Articles

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

April 22, 2005